A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
about
Bifunctional Phosphorus Dendrimers and Their PropertiesThe Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisImmunosuppressive and anti-inflammatory properties of engineered nanomaterialsNanoparticles and direct immunosuppressionDendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriersThe key role of the scaffold on the efficiency of dendrimer nanodrugs.Selectivity in bone targeting with multivalent dendritic polyanion dye conjugates.Particle-based technologies for osteoarthritis detection and therapy.Polymeric drugs: Advances in the development of pharmacologically active polymers.Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers.Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injuryEngineering nano- and microparticles to tune immunityNanomedicine in cerebral palsy.Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.GATG dendrimers and PEGylated block copolymers: from synthesis to bioapplications.The dendritic effect illustrated with phosphorus dendrimers.Recent advances in targeted drug delivery approaches using dendritic polymers.Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo.The specific functionalization of cyclotriphosphazene for the synthesis of smart dendrimers.Inorganic dendrimers: recent advances for catalysis, nanomaterials, and nanomedicine.Nanomedicines for dysfunctional macrophage-associated diseases.Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes.Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles.Nanoscale effects in dendrimer-mediated targeting of neuroinflammation[Using dendrimers for an innovative nanomedicine].Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies.Phosphorus dendrimers as carriers of siRNA--characterisation of dendriplexes.Fluorescent Phosphorus Dendrimer as a Spectral Nanosensor for Macrophage Polarization and Fate Tracking in Spinal Cord Injury.Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.Multivalent nanosystems: targeting monocytes/macrophagesA Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ ToxicityNanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs
P2860
Q26749383-B73E9A14-E539-47C7-86E9-3F2ABFF0A26DQ26774681-16C2D566-A923-48DE-865E-4BD56EE73367Q27005267-1AC7315B-3F4B-4AC7-A836-D5F96E4C52D6Q28384480-EEBAE5F0-01D5-492C-A155-841159FB227AQ30528069-3AD43CCC-B1ED-4A81-B108-8F3CA94823ADQ30546346-F5FFE579-4F2B-4090-AF53-0CC5D1719891Q30658594-920432E0-B48E-4704-B505-B797F88AF757Q31136234-F1356659-17E0-4561-A711-DB7D4230F7D8Q36303687-154CB8E2-A417-4B53-9DF3-15C27B42E596Q36307604-E6A3DBC4-F82C-46EE-A22E-BD469F7CEF0AQ36379497-4AFFCDD4-7CCF-42F2-9FD4-39CDCDB46D90Q36520379-BF4D6DC9-4CEE-418F-A674-AF12DF90A355Q37205125-8A9509AA-4A8B-43A1-9480-5D389AB852B4Q37281194-D1399872-A6F2-4C9E-8E90-5208CA39157DQ37731623-56509E8D-A807-4FDF-B1F8-83FD0509BBFDQ38064420-723ED9FB-4C69-4A68-8614-025F963A9901Q38075542-5134A8C0-36D5-4DD3-B892-2780E3FD4428Q38227356-ECB810C0-A6ED-4438-AC7E-61BA968E6255Q38258240-DD35BB82-EBDB-42A0-BFD5-E34F2F760857Q38556761-9FB29C31-2233-4A89-9F12-4E5FFDED95B6Q38605152-EEC9024F-3FFA-4F17-B3A6-D483E6799584Q38622568-37609E5B-340D-4ABB-8E51-877964434053Q38758579-10495178-E376-4A33-9EBA-C73DDEE386D6Q39069052-5ED705CF-4098-44AA-9C3D-2EF016FD93A5Q40579361-7493887A-78CF-44EF-B81A-AA2A2C9AB114Q40794011-E57182BA-9D6F-40CE-9234-8757D6A537F2Q41667031-26D000BB-DA76-4A14-B4CF-F74147B0459EQ41992016-83726F6F-5BE1-4331-B8E5-EFB9EF2EF3B7Q46836981-47A9886D-4427-4A68-B2C8-6C498DFFE121Q47429306-D21C1D68-80A1-459F-8A7C-B2109033125EQ47633780-547E866B-D8C2-4AEC-87ED-9C5C7DDE0589Q48661111-A53DC6C9-ECCD-4A0C-BF88-18FBB94A6195Q49790704-80E9D74A-4533-41A5-BF23-BFB798F7B5A5Q57073314-E8F58EF2-3F62-47DC-9775-D83D0F32AE65Q57823849-36FB2B81-F1F1-46CE-978F-64F4462230E4Q58910462-26BB113B-B302-4295-AC15-B0C332E87002
P2860
A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@en
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@nl
type
label
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@en
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@nl
prefLabel
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@en
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@nl
P2093
P2860
P50
P1476
A phosphorus-based dendrimer t ...... sis in experimental arthritis.
@en
P2093
Alain Cantagrel
Delphine Nigon
Jean-Luc Davignon
Mary Poupot
Michel Baron
Myriam Hayder
Robert A Eisenberg
Rémy Poupot
P2860
P304
P356
10.1126/SCITRANSLMED.3002212
P407
P577
2011-05-01T00:00:00Z